SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's Lab reports Profit after tax of Rs 4490.00 Mln, in the September 2021 quarter

29 Oct 2021 Evaluate
A fair growth of 14.27% in the revenue at Rs. 38234.00 millions was reported in the September 2021 quarter as compared to Rs. 33458.00 millions during year-ago period.The Net Profit of the company registered a slight decline of -6.65% to Rs. 4490.00  millions from Rs. 4810.00 millions.Operating Profit saw a handsome growth to 8664.00 millions from 8432.00 millions in the quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 38234.00 33458.00 14.27 72569.00 65902.00 10.12 133491.00 118504.00 12.65
Other Income 1181.00 266.00 343.98 3043.00 6713.00 -54.67 8011.00 7432.00 7.79
PBIDT 8664.00 8432.00 2.75 16145.00 24166.00 -33.19 39379.00 36128.00 9.00
Interest 111.00 93.00 19.35 176.00 233.00 -24.46 467.00 478.00 -2.30
PBDT 8553.00 8339.00 2.57 15969.00 23933.00 -33.28 38912.00 35650.00 9.15
Depreciation 2066.00 2142.00 -3.55 4037.00 4119.00 -1.99 8350.00 7892.00 5.80
PBT 6487.00 6197.00 4.68 11932.00 19814.00 -39.78 30562.00 27758.00 10.10
TAX 1997.00 1387.00 43.98 3308.00 5502.00 -39.88 8698.00 -1619.00 -637.25
Deferred Tax 841.00 273.00 208.06 1168.00 1997.00 -41.51 3297.00 -6458.00 -151.05
PAT 4490.00 4810.00 -6.65 8624.00 14312.00 -39.74 21864.00 29377.00 -25.57
Equity 832.00 831.00 0.12 832.00 831.00 0.12 832.00 831.00 0.12
PBIDTM(%) 22.66 25.20 -10.08 22.25 36.67 -39.33 29.50 30.49 -3.24

Dr. Reddys Labs. Share Price

1356.85 -19.45 (-1.41%)
30-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.70
Dr. Reddys Labs. 1356.85
Cipla 1465.15
Zydus Lifesciences 1112.20
Lupin 2420.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: